The U.S. Food and Drug Administration's (FDA) approval rate for novel drugs reached a 19-year high with 45 new drugs hitting the market.
The FDA approved the drug combination of Cotellic (cobimetrinib) with Zelboraf (vemurafenib) for patients with a specific form of melanoma.
The non-electric inhaler, Voke, created by Nicoventures, which is a subsidiary of British American Tobacco, can soon be prescribed as a smoking cessation aid.
The FDA has approved a new prescription pill for insomnia.
Amgen Inc. announced that its blood cancer drug was capable of extending the lives of patients suffering from multiple myeloma.
A new study reported that parental interference can negatively affect their children's relationships.
Orexigen Therapeutics' diet pill, Contrave is expected to be approved by the U.S. Food and Drug Administration.
The FDA has approved the Deka Arm for amputees.
The FDA approved Tanzeum, an injectable drug for type 2 diabetes.
Democrat Joe Manchin urged the FDA to overturn its approval for the new pain drug, Zohyrdo.
Drugmaker Endo Pharmaceuticals said Thursday that it received approval from the country for its long-acting testosterone injection Aveed. The drug Aveed joins an already crowded market of hormone-boosting drugs that aim at aging American men.
A new study reported that the FDA's approval process varies greatly based on the drug.
In a new clinical trial, researchers found that an ADHD drug was effective in treating binge eating.
A new study published in JAMA found that in 2008, eight drugs where approved faster due to expedited review.
UK drug manufacturing company, GlaxoSmithKline is seeking regulatory approval for RTS,S, the world's first ever malaria vaccine.
They may not be scientifically based, but the need for a solution outside of pharmaceuticals may encourage you to consider such options. When traditional medicine is not quite doing the trick, thinking outside the box and trying one of these options may bring surprising results.